Fluorine-18 is among the most commonly used radionuclides for positron emission tomography
(PET).[1] This non-invasive imaging technique is capable of providing in vivo information …

In this short review we describe recent methods and novel trends for the introduction of
fluorine-18 into molecules which in turn are intended to serve as imaging agents for the in vivo …

The syntheses of different 18 F-labeled peptides using the highly effective labeling synthon
p-(di-tert-butylfluorosilyl) benzaldehyde ([ 18 F]SiFA-A) for the development of 18 F-…

Here we present a procedure to label peptides with the positron-emitting radioisotope
fluorine-18 (18 F) using the silicon-fluoride acceptor (SiFA) labeling methodology. Positron …

Broad spectrum: Novel para‐functionalized aryl‐di‐tert‐butylfluorosilanes, p‐(tBu 2 FSi)C 6
H 4 X (X=functional group), have been made available and broaden the spectrum of silicon‐…

Prosthetic group (PG) applications in 18 F-radiochemistry play a pivotal role among current
18 F - labeling techniques for the development and availability of 18 F-labeled imaging …

Radiosyntheses of 18 F-radiopharmaceuticals for positron emission tomography (PET)
normally require an extraordinarily high effort of technical equipment and specially trained …

Background. Over the recent years, radiopharmaceutical chemistry has experienced a wide
variety of innovative pushes towards finding both novel and unconventional radiochemical …

The DNA methyltransferase inhibitors 5-azacytidine (5-azaCyd) and 5-aza-2′-deoxycytidine
have found increasing use for the treatment of myeloid leukemias and solid tumors. Both …

Molecular imaging offers unprecedented opportunities for investigating dynamic changes
underlying neuropsychiatric conditions. Here, we evaluated whether [ 11 C]ABP688, a positron …